AGN
ARGENICA FPO [AGN]
Healthcare · ASX Small Cap
$0.1650 +0.0%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical31
Catalyst54
Sentiment50
Fundamental44
Momentum19
Risk Gate42
Get alerts when AGN's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- RSI is looking oversold — historically a spot where stocks tend to bounce
- Stochastic is deep in oversold territory — bounce conditions forming
- Volume surging at 2.3x normal while price falls — heavy selling pressure
- Took a hit — down 17.5% over the last 5 days
- Lagging the Small Ords index — relative strength of 0.84, underperforming its peers
- Volatility is expanding fast — choppy price action, so buckle up
- Low cash runway (2 quarters) - dilution risk
- Revenue in sharp decline (-78%)
- Near 52-week low (0% of range)
- Small-cap ($20-100M)
- Sentiment is mixed — no strong consensus either way
- This one has been in freefall — down 73% over the past year
- Altman Z-Score distress zone (0.57 < 1.81, low-confidence approx)
- RBA hiking (-3pts)
Risk Signals
- Trading below both moving averages — the trend is working against this one
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (3/9, low-confidence approx)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Revenue declining at -78% — the top line is shrinking
- The bigger volume days are the down days — volume-weighted momentum is negative (-3.24%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about AGN
3 free messages/day · Unlimited with Pro
Recent Catalysts
LOW Presentations at European Stroke Organisation Conference
LOW Investor Presentation - Euroz Hartleys Healthcare Conference
NONE Argenica Receives $3.97m R&D Tax Incentive Cash Rebate
NONE Half Yearly Report and Accounts
NONE Successful Applicaton for EMA Paediatric Waiver
Recent ASX Announcements
| 2026-03-25 | Presentations at European Stroke Organisation Conference PRICE SENSITIVE |
| 2026-03-16 | Argenica Receives $3.97m R&D Tax Incentive Cash Rebate PRICE SENSITIVE |
| 2026-02-10 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-04 | Investor Presentation - Euroz Hartleys Healthcare Conference |
| 2026-02-01 | Successful Applicaton for EMA Paediatric Waiver PRICE SENSITIVE |
Key Metrics
$21.2M
Market Cap
168K
Avg Volume
2.3x
Vol Ratio
$0.17 — $0.85
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-117.8%
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 72% |
| L | Leader vs Laggard | laggard | RS: -10 |
| I | Institutional Sponsorship | weak | Inst: 1% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #79 of 117 · Sector avg: 46
View all Healthcare signals →Track AGN and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required